newsfilter
← Latest News
FDA Approved Drugs·

Approval of Cardamyst, Nda #218571 (Type 1 - New Molecular Entity)

Approval Date: 12/12/2025; Drug Name: Cardamyst, Nda #218571; Active Ingredients: ETRIPAMIL; Company: Milestone Pharmaceuticals Usa, Inc.; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 218571

Company
Milestone Pharmaceuticals USA, Inc.
Keywords
Milestone Pharmaceuticals USA, Inc.